By-Health
Last updated August 31, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
History
By-Health was established in 1995 in China by Liang Yunchao. The company entered the nutritional-supplement field at a time when consumer interest in vitamins, minerals, health foods, and imported wellness products was increasing. It built its business around the development, sourcing, production, marketing, and distribution of non-prescription nutritional products rather than pharmaceutical medicines. During its expansion, By-Health developed a broad product range covering vitamins and minerals, protein, fish oil, probiotics, plant extracts, and specialized nutrition. The company used a multichannel distribution model that included pharmacies, supermarkets, health-product stores, and online platforms. Its branding and packaging generally presented supplementation as part of regular health management and lifestyle consumption. This approach helped it become a highly recognizable domestic brand in China’s dietary-supplement sector. The company’s public-market transition was an important milestone. By-Health was listed on the Shenzhen Stock Exchange’s ChiNext board in 2010 under ticker 300146. The listing provided a source of capital and increased disclosure obligations as the company expanded manufacturing, quality systems, research capabilities, marketing, and retail coverage. It also placed the business within the competitive and regulated environment of China’s publicly traded consumer-health sector. By-Health later pursued a combination of organic expansion and acquisition. Its purchase of Australian probiotics company Life-Space in 2017 broadened the group’s probiotics offering and gave it a stronger international platform. The transaction reflected a wider strategy among Chinese consumer-health companies: combine domestic distribution and brand recognition with overseas brands, ingredients, research, and manufacturing capabilities. The company’s business remains centered on nutritional supplements sold mainly in China, while international sourcing and overseas activities support selected product categories. Its portfolio serves general wellness and more targeted consumer needs, including nutrition for children, women, older adults, and sports participants. Products are regulated according to the legal classification and market in which they are sold, and the company’s claims and advertising must comply with food, health-food, labeling, and advertising requirements. By-Health is an active public company and a recognized participant in China’s nutritional-supplement market. Current details about its leadership, revenue, market share, overseas footprint, and product registrations should be taken from the latest company filings because those details can change over time.
- 2017
Life-Space acquisition
[1]By-Health acquired Australian probiotics company Life-Space, broadening its probiotics portfolio and international operations.
- 2010
Shenzhen listing
[2]By-Health became listed on the Shenzhen Stock Exchange’s ChiNext market under ticker 300146.
- 1995
Company founded
[1]Liang Yunchao founded By-Health in China, establishing the business that would develop into a major domestic nutritional-supplement company.
Products and positioning
Mass-premium to mid-to-high-end dietary and nutritional supplements, with an emphasis on everyday wellness, ingredient sourcing, quality control, and broad retail availability.
Dietary supplements
Vitamins and minerals
By-Health’s vitamins-and-minerals portfolio includes single-nutrient and combination products intended for everyday nutritional supplementation. Products in this category are commonly formulated around nutrients such as vitamin C, vitamin D, calcium, zinc, and multivitamin combinations, with variations for different age groups and consumer needs. Exact formulations, classifications, and permitted claims vary by product and market.
Sports and active nutrition
Protein and sports nutrition
Protein powders and related sports-nutrition products are designed for consumers seeking supplemental protein and nutrition around exercise or active lifestyles. The range has helped By-Health participate in the growing overlap between traditional dietary supplements, fitness consumption, and performance-oriented nutrition. Product ingredients and usage guidance differ across formulations.
Specialty dietary supplements
Fish oil and omega-3 supplements
Fish-oil products provide a widely marketed supplement format based on omega-3 fatty acids. By-Health has offered fish-oil products within its broader nutrition portfolio, targeting consumers interested in general wellness and dietary supplementation. They are consumer health products and should not be treated as a replacement for medical care.
Digestive-health supplements
Probiotics
Probiotics became a strategically important category for By-Health, particularly after its acquisition of Life-Space in Australia. The portfolio includes products built around different probiotic strains and formats, including products for general digestive-health use and age- or need-specific consumption. Product claims and regulatory treatment depend on the market and formulation.
Botanical supplements
Herbal and plant-extract supplements
The company’s wider product architecture includes supplements using botanical or other plant-derived ingredients. These products extend the brand beyond basic vitamins and minerals and address consumers looking for traditional, natural, or lifestyle-oriented nutrition products. The ingredients and allowable communications differ according to product registration and local rules.
Brand decisions
2017
Acquisition of Life-SpaceM&ABackground
By-Health sought to strengthen its probiotics business and international capabilities through an overseas acquisition.
Action taken
The company acquired Australian probiotic brand and business Life-Space.
Aftermath
The acquisition added an established probiotics platform to By-Health’s portfolio and increased the group’s exposure to Australia and international consumer-health markets.
2010
Public-market expansionStrategyBackground
By-Health required additional capital and organizational capacity to expand its products, manufacturing, brand investment, and distribution network.
Action taken
The company completed a listing on the Shenzhen Stock Exchange’s ChiNext market.
Aftermath
The listing increased the company’s access to public capital and subjected it to continuing exchange disclosure and governance requirements.
Recent events
- Unconfirmed
By-Health delays Australian production base and digital system projects to 2029[3]
Reported:
By-Health's Australian production base construction project and digital information system project, originally scheduled for completion by June 30, 2026, have been postponed to June 30, 2029, involving 674 million yuan in raised funds. The Zhuhai production base phase V project progress was only 23.96% as of the report period.
By-Health reports 2026 half-year results with revenue growth but profit decline[3]
Reported:
By-Health released its 2026 half-year report, showing revenue of 3.671 billion yuan, up 3.94% year-on-year, while net profit attributable to shareholders fell 18.11% to 603 million yuan. Online channel revenue exceeded 50% of total revenue for the first time, but selling expenses rose 25.25% and operating cash flow shrank sharply.
汤臣倍健 and Zhuhai People's Hospital Medical Group form strategic partnership[4]
Reported:
汤臣倍健 and Zhuhai People's Hospital Medical Group formed a strategic partnership and jointly launched a research platform focused on nutrition intervention for chronic-disease risks in older adults.
By-Health announces investment to acquire 80% of its e-commerce distributor[5]
Reported:
By-Health announced that it would invest RMB 80 million to obtain an 80% equity stake in Guangzhou Maiyou Network Technology, the e-commerce general distributor for its By-Health brand.
By-Health reports first-half 2020 results[5]
Reported:
By-Health disclosed its 2020 half-year results on the evening of July 29, reporting revenue of RMB 3.125 billion, up 5.23% year over year, and net profit attributable to shareholders of RMB 962 million, up 10.96%.
By-Health upgrades its brand identity[5]
Reported:
By-Health restarted its brand upgrade in May, adopting a new logo and new packaging across its product line, and upgrading the appearance of its terminal stores.
By-Health forecasts a 2019 net loss[6]
Reported:
By-Health issued a 2019 performance forecast projecting a net loss attributable to shareholders of 365 million to 370 million yuan, compared with net profit of 1.002 billion yuan in 2018. The article says the forecast included impairment provisions related to its acquisition of LSG.
BY-Health forecasts a 2019 net loss[7]
BY-Health announced that it expected a 2019 net loss of 365 million to 370 million yuan. The article says the forecast followed impairment provisions related to its acquisition of LSG and investments in other companies.
汤臣倍健 and Fonterra sign strategic cooperation agreement[8]
Reported:
汤臣倍健 and Fonterra signed a strategic cooperation agreement to collaborate in milk proteins and selected probiotics, including ingredient research, evaluation and product development.
Sources10 sources
- 1By-Health official websiteby-health.com
- 2Shenzhen Stock Exchangeszse.cn
- 3汤臣倍健澳洲生产基地及数字化信息系统项目延期至2029年finance.sina.com.cn
- 4汤臣倍健与珠海市人民医院医疗集团达成战略合作prnasia.com
- 5汤臣倍健宣布增资取得电商总经销商80%股权finance.sina.com.cn
- 6汤臣倍健预告2019年净亏损tech.sina.com.cn
- 7汤臣倍健预告2019年亏损sc.stock.cnfol.com
- 8汤臣倍健与恒天然签署战略合作协议finance.sina.com.cn
- 9汤臣倍健发布三季报，公司推动一系列创新prnasia.com
- 10汤臣倍健商誉雷：上市10年首次亏损，都是收购LSG惹得祸finance.sina.com.cn
Cite this profile: Cite the canonical profile. /brand-wiki/by-health · Editorial policy · How profiles are compiled